243 related articles for article (PubMed ID: 12710291)
1. [Factors influencing secondary prevention of atherothrombotic disease in the private outpatient cardiology setting: results of the Prisma survey].
Cambou JP; Ferrieres J; Grenier O; Boka G; Cantet C; Leizorovicz A
Ann Cardiol Angeiol (Paris); 2003 Feb; 52(1):20-9. PubMed ID: 12710291
[TBL] [Abstract][Full Text] [Related]
2. [Management of the cardiology patient with polyvascular disease: PRISMA study].
Cournot M; Cambou JP; Ferrières J; Grenier O; Herrmann MA; Cantet C; Leizorovicz A
Arch Mal Coeur Vaiss; 2004 Sep; 97(9):841-8. PubMed ID: 15521475
[TBL] [Abstract][Full Text] [Related]
3. [Evolution of secondary prevention medication prescriptions after myocardial revascularisation: the ANCOR survey].
Jullien G; Mosnier M; Danchin N
Ann Cardiol Angeiol (Paris); 2005 Aug; 54(4):184-9. PubMed ID: 16104618
[TBL] [Abstract][Full Text] [Related]
4. Comparison of cardiovascular risk factors and drug use in 14,544 French patients with a history of myocardial infarction, ischaemic stroke and/or peripheral arterial disease.
Bongard V; Cambou JP; Lezorovcz A; Ferrères J; Vahanan A; Jullen G; Coppe G; Guerllot M; Herrmann MA; Mas JL
Eur J Cardiovasc Prev Rehabil; 2004 Oct; 11(5):394-402. PubMed ID: 15616412
[TBL] [Abstract][Full Text] [Related]
5. Secondary medical prevention among Danish patients hospitalised with either peripheral arterial disease or myocardial infarction.
Gasse C; Jacobsen J; Larsen AC; Schmidt EB; Johannesen NL; Videbaek J; Sørensen HT; Johnsen SP
Eur J Vasc Endovasc Surg; 2008 Jan; 35(1):51-8. PubMed ID: 17923426
[TBL] [Abstract][Full Text] [Related]
6. [Drug prescription in the post-percutaneous coronary interventions period: results of the ECART study].
Philippe F; Sebaoun A; Avierinos C; Julien G
Ann Cardiol Angeiol (Paris); 2004 Jun; 53(3):131-6. PubMed ID: 15291168
[TBL] [Abstract][Full Text] [Related]
7. Prevalence and correlates of non-optimal secondary medical prevention in patients with stable coronary artery disease.
Meurice T; Tricot O; Lemesle G; Deneve M; Lejeune P; Biausque F; Cordier C; Savoye C; Hennebert O; Taghipour K; Sivery B; Pruvost P; Alaoui M; Carpentier L; Segrestin B; Lamblin N; Bauters C
Arch Cardiovasc Dis; 2015; 108(6-7):340-6. PubMed ID: 25858539
[TBL] [Abstract][Full Text] [Related]
8. [Changes in the prescription of cardiovascular prevention drugs in France between 1995 and 2003: factors influencing the gap between evidence base medicine and clinical practice].
Philippe F; Cambou JP; Danchin N; Thomas D
Ann Cardiol Angeiol (Paris); 2005 Dec; 54 Suppl 1():S30-6. PubMed ID: 16411649
[TBL] [Abstract][Full Text] [Related]
9. Appropriate secondary prevention and clinical outcomes after acute myocardial infarction according to atherothrombotic risk stratification: The FAST-MI 2010 registry.
Tea V; Bonaca M; Chamandi C; Iliou MC; Lhermusier T; Aissaoui N; Cayla G; Angoulvant D; Ferrières J; Schiele F; Simon T; Danchin N; Puymirat E;
Eur J Prev Cardiol; 2019 Mar; 26(4):411-419. PubMed ID: 30354737
[TBL] [Abstract][Full Text] [Related]
10. The use of secondary medical prevention after primary vascular reconstruction: studies on usage and effectiveness.
Høgh AL
Dan Med J; 2012 Sep; 59(9):B4514. PubMed ID: 22951205
[TBL] [Abstract][Full Text] [Related]
11. Decade-Long Trends (2001 to 2011) in the Use of Evidence-Based Medical Therapies at the Time of Hospital Discharge for Patients Surviving Acute Myocardial Infarction.
Makam RC; Erskine N; McManus DD; Lessard D; Gore JM; Yarzebski J; Goldberg RJ
Am J Cardiol; 2016 Dec; 118(12):1792-1797. PubMed ID: 27743577
[TBL] [Abstract][Full Text] [Related]
12. Optimal medical management of peripheral arterial disease.
Rice TW; Lumsden AB
Vasc Endovascular Surg; 2006; 40(4):312-27. PubMed ID: 16959725
[TBL] [Abstract][Full Text] [Related]
13. Baseline clinical characteristics and patient profile of the TURKMI registry: Results of a nation-wide acute myocardial infarction registry in Turkey.
Erol MK; Kayıkçıoğlu M; Kılıçkap M; Arın CB; Kurt IH; Aktaş I; Güneş Y; Özkan E; Şen T; Ince O; Örnek E; Asoğlu R; Aladağ N; Zeybey U; Sinan ÜY; Dural M; Tüner H; Doğan A; Yenerçağ M; Akboğa M; Deveci OS; Somuncu MU
Anatol J Cardiol; 2020 Jul; 24(1):43-53. PubMed ID: 32628144
[TBL] [Abstract][Full Text] [Related]
14. Regional and practice variation in adherence to guideline recommendations for secondary and primary prevention among outpatients with atherothrombosis or risk factors in the United States: a report from the REACH Registry.
Kumar A; Fonarow GC; Eagle KA; Hirsch AT; Califf RM; Alberts MJ; Boden WE; Steg PG; Shao M; Bhatt DL; Cannon CP;
Crit Pathw Cardiol; 2009 Sep; 8(3):104-11. PubMed ID: 19726929
[TBL] [Abstract][Full Text] [Related]
15. Use of recommended medications after myocardial infarction in Austria.
Winkelmayer WC; Bucsics AE; Schautzer A; Wieninger P; Pogantsch M;
Eur J Epidemiol; 2008; 23(2):153-62. PubMed ID: 18064529
[TBL] [Abstract][Full Text] [Related]
16. Peripheral arterial disease versus other localizations of vascular disease: the ATTEST study.
Blacher J; Cacoub P; Luizy F; Mourad JJ; Levesque H; Benelbaz J; Michon P; Herrmann MA; Priollet P
J Vasc Surg; 2006 Aug; 44(2):314-8. PubMed ID: 16890860
[TBL] [Abstract][Full Text] [Related]
17. [SECONDARY PREVENTION IN PATIENTS WITH ACUTE CORONARY SYNDROME HOSPITALIZED IN INTERNAL MEDICINE DEPARTMENTS].
Yahia DH; Pereg D; Lishner M; Elis A
Harefuah; 2015 May; 154(5):299-302, 339-40. PubMed ID: 26168639
[TBL] [Abstract][Full Text] [Related]
18. ACE up the sleeve - are vascular patients medically optimized?
Coveney AP; O'Brien GC; Fulton GJ
Vasc Health Risk Manag; 2011 Jan; 7():15-21. PubMed ID: 21339909
[TBL] [Abstract][Full Text] [Related]
19. [Evaluation of management of infarction in the Franche Comté province by the use of the Franche Comté Cardiology Registry, May 2005-May 2006].
Schiele F; Fouché R; Lassabe G; Bohigas P; Magnin D; Bechetoille P; Thebault L; Faivre R; Boumal D; Frison J; Bassand JP;
Arch Mal Coeur Vaiss; 2007 Nov; 100(11):917-24. PubMed ID: 18209692
[TBL] [Abstract][Full Text] [Related]
20. Antithrombotic treatment and characteristics of elderly patients with non-valvular atrial fibrillation hospitalized at Internal Medicine departments. NONAVASC registry.
Gullón A; Suárez C; Díez-Manglano J; Formiga F; Cepeda JM; Pose A; Camafort M; Castiella J; Rovira E; Mostaza JM;
Med Clin (Barc); 2017 Mar; 148(5):204-210. PubMed ID: 27993408
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
